The aim of this study is to evaluate the pain-relieving effect of a novel chemokine signal-inhibiting compound on allodynia-specific responses in a chronic pain animal model, using our BOLD-fMRI-based pain evaluation system with a green laser. We observed activations in four brain regions related to pain. We found that the compound suppresses green laser-evoked allodynia-specific responses in three regions. We expect that the compound has synergistic pain-relieving effects with existing analgesic agents. Our system is useful to evaluate the effects of new analgesic candidates in non-clinical and, expectantly, clinical studies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords